Edaravone Dexborneol Alleviates Neuroinflammation by Reducing Neuroglial Cell Proliferation and Suppresses Neuronal Apoptosis/Autophagy in Vascular Dementia Rats
Authors:
- 20 June 2023
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 48 (10) , 3113-3128
Abstract
More and more evidence shows that the pathological mechanism of vascular dementia (VD) is closely related to oxidative stress injury, cell apoptosis, autophagy, inflammatory response, excitatory amino acid toxicity, synaptic plasticity change, calcium overload, and other processes. Edaravone dexborneol (EDB) is a new type of neuroprotective agent that can improve the neurological damage caused by an ischemic stroke. Previous studies showed that EDB has effects on synergistic antioxidants and induces anti-apoptotic responses. However, it remains unclear whether EDB can affect apoptosis and autophagy by activating the PI3K/Akt/mTOR signaling pathway and its impact on the neuroglial cells. In this study, we established the VD model of rats by bilateral carotid artery occlusion to explore the neuroprotective effect of EDB and its mechanism. Morris Water Maze test was applied to assess the cognitive function of rats. H&E and TUNEL staining were applied to observe the cellular structure of the hippocampus. Immunofluorescence labeling was used to observe the proliferation of astrocytes and microglia. ELISA was applied to examine the levels of TNF-α, IL-1β and IL-6, and RT-PCR was applied to examine their mRNA expression levels. Western blotting was applied to examine apoptosis-related proteins (Bax, Bcl-2, Caspase-3), autophagy-related proteins (Beclin-1, P62, LC3B), PI3K/Akt/mTOR signaling pathway proteins and their phosphorylation levels. The results indicated that EDB ameliorates learning and memory in rats subjected to the VD model, alleviates neuroinflammatory response by reducing the proliferation of the neuroglial cell and inhibits apoptosis and autophagy, which may be mediated by the PI3K/Akt/mTOR signaling pathway.Keywords
Funding Information
- Hebei Provincial High-end Talent Support Program (No. 2019-63)
- Hebei Provincial Government Funded Clinical Medicine Outstanding Talent Training Program (No. 2019-139)
- Hebei Provincial Science and Technology Innovation Team (No.2020-9)
This publication has 42 references indexed in Scilit:
- Vascular dementiaThe Lancet, 2015
- Baclofen mediates neuroprotection on hippocampal CA1 pyramidal cells through the regulation of autophagy under chronic cerebral hypoperfusionScientific Reports, 2015
- Alternatively activated microglia and macrophages in the central nervous systemProgress in Neurobiology, 2015
- Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signalingBMC Complementary and Alternative Medicine, 2015
- The PI3K/AKT/mTOR interactive pathwayMolecular BioSystems, 2015
- Astrocyte Reactivity and Reactive Astrogliosis: Costs and BenefitsPhysiological Reviews, 2014
- Edaravone for acute stroke: Meta-analyses of data from randomized controlled trialsDevelopmental Neurorehabilitation, 2013
- The Novel Free Radical Scavenger, Edaravone, Increases Neural Stem Cell Number Around the Area of Damage Following Rat Traumatic Brain InjuryNeurotoxicity Research, 2009
- Neuroprotective Effects of Edaravone: a Novel Free Radical Scavenger in Cerebrovascular InjuryCNS Drug Reviews, 2006
- Evidence for a Role of Second Pathophysiological Stress in Prevention of Delayed Neuronal Death in the Hippocampal CA1 RegionNeurochemical Research, 2005